MedCity News September 29, 2024
The Federal Trade Commission has sued CVS Caremark, Express Scripts and Optum Rx, alleging that they engage in “anticompetitive and unfair rebating practices” as it relates to insulin. One legal expert believes the FTC might win this legal battle.
Shortly after releasing a scathing interim report in July that revealed how three players dominate the pharmacy benefit manager market and raise drug costs for patients, the Federal Trade Commission is turning its words into action.
Late last week, the agency sued the three largest PBMs — CVS Caremark, Express Scripts and Optum Rx — and their affiliated group purchasing organizations for “engaging in anticompetitive and unfair rebating practices” as it relates to insulin. For example, the PBMs use restrictive drug...
Today's Sponsors
Today's Sponsor